Study Title: A Phase 4 Study to Assess the Clinical Efficacy of H.P. Acthar Gel 80 U/ml to Improve the Signs and Symptoms in Subjects With Dry Eye Disease
Phase of Trial: Phase IV
Latest Information Update: 03 Sep 2018
At a glance
- Drugs Corticotropin (Primary)
- Indications Dry eyes
- Focus Adverse reactions; Therapeutic Use
- 23 Aug 2018 Planned End Date changed from 31 Jul 2018 to 31 Jul 2019.
- 23 Aug 2018 Planned primary completion date changed from 31 May 2018 to 31 May 2019.
- 23 Aug 2018 Status changed from not yet recruiting to recruiting.